Review Chargebacks at a Shared Facility Before Renewal

Shared facilities pay for their equipment and staff through internal chargebacks, and that funding model rarely lines up with a vendor's renewal calendar. A strategic account manager who treats strong usage numbers as a sign that the deal is ready to close will run into a wall the facility director cannot move on their own. The real work is finding out who actually approves the money before you build a renewal timeline around a date nobody controls.

Why This Conversation Goes Wrong

Facility directors run the day to day science. They watch the samples move through the core, they hear from happy lab managers, and they genuinely want to keep the service running. None of that means they set the budget. In an academic or biotech shared facility, imaging cores, sequencing cores, and mass spec labs included, the chargeback rate usually gets set or reviewed by a finance office, a faculty oversight committee, or both, on a schedule that has nothing to do with your renewal date. If you ask the director whether you are good to renew and hear that users love the service, you have learned something true about usage and nothing about budget. Account managers who skip past that distinction end up proposing terms to a person who cannot sign them, then scrambling when the real reviewer surfaces late with a different number or a different timeline. The renewal does not fail because the science stopped working. It stalls because nobody mapped the actual approval path before the proposal went out.

How to Prepare Before You Meet

Before you sit down with the facility director, write out what you do not know yet. Then go find the answers to these questions.

1. Who receives the chargeback invoice, and who actually sets the facility's budget for the year.
2. When does the institution next review its rates or allocations, and who runs that review.
3. Which labs use the service today, and which lab leader can speak credibly to future demand.
4. If commercial terms come up, who is the authorized customer contact for that discussion, separate from the day to day facility director.

Usage volume matters here because it builds the case for renewal, even when it has no formal role in approving it. Keep that distinction straight in your own head, because it is easy to let strong usage numbers stand in for budget approval when you want the deal to move.

This is the same discipline that matters on a straight platform renewal. Surface Dependencies for a Shared Platform Renewal Before a Commercial Review lays out how to map who controls budget, who controls usage, and who controls the signature before you let a commercial conversation move forward. Shared facility chargebacks are a specific version of that same problem, with a finance office and a faculty committee standing in for the more typical procurement chain.

What to Say When the Chargeback Review Comes Up

Picture a renewal check in with Rosa, who directs a shared imaging facility. Rosa opens with good news wrapped around a warning. She says, "Our labs want to keep using the service, but we are in the middle of reviewing how we charge back the cost internally, so I cannot commit to numbers yet."

Instead of pushing past that or treating it as a soft yes, the account manager stays on the process. "Let's map that review so we know who needs to be part of this conversation. Who owns the decision on the new rate, and when will the facility know what budget got approved."

Rosa names a finance analyst who models the rate and a faculty committee that has to sign off on it, with the committee meeting scheduled in six weeks. The account manager responds by separating the two conversations cleanly. "Then let's keep today focused on the service itself and what your labs actually need going forward. I will hold off on proposing renewal terms until the committee has met, and I would like a short planning call with you right after that decision, before anything goes to your finance analyst."

Rosa agrees and adds one more detail, that the committee usually asks for a usage summary from the labs before it votes. The account manager offers to help pull that summary together from the account's own usage data, which gives Rosa something useful to bring to the committee and gives the account manager a reason to stay engaged during the review instead of waiting on the sidelines.

That exchange does three things. It gets the review out in the open instead of leaving it implied. It names the two people who actually matter to the timeline. And it keeps the account manager from locking in terms that the facility has no authority yet to accept.

Mistakes to Avoid

A few habits turn this kind of conversation into a stalled renewal.

1. Treating the director's enthusiasm as budget approval, then building a proposal timeline around it, forces an awkward reset later when the real number comes from finance.
2. Negotiating price or contract language with someone who is not the authorized commercial contact wastes both sides' time and can create confusion about what was actually offered.
3. Skipping the question about governance timing means you find out about the faculty committee only after your proposal has already gone stale.
4. Folding unresolved chargeback terms into a signed renewal just moves the disagreement later, where it costs more to fix and looks worse to the customer.
5. Leaving the meeting without a specific date for the next conversation lets the whole renewal drift, because nobody on the customer side is going to chase you down to schedule it.

Any one of these mistakes turns a solvable timing problem into a lost quarter. Together, they make the renewal look uncertain to your own leadership, when the underlying demand from the labs was never actually in question.

How to Practice and Score This Conversation

This conversation rewards preparation more than charisma, which makes it a good one to rehearse before it happens for real. A manager coaching an account team should score three things.

1. Did the account manager ask about the chargeback process before assuming approval, rather than taking usage enthusiasm at face value.
2. Did they correctly separate the service conversation from the commercial one once contract terms came up.
3. Did they leave the meeting with a named owner, a real date, and a clear next step, rather than a vague promise to check back in.

Run through the exchange with a partner playing the facility director, and have that partner introduce a review or a committee the way Rosa does, then watch whether the account manager tries to close anyway or slows down to map the decision. DealSpeak is built for this kind of rehearsal, since it lets you run the scenario against an AI counterpart and get scored on whether you found the real owners instead of accepting the first friendly answer. For a broader set of scenarios in this space, the Biotechnology practice conversations cover related situations, including how to Plan a Laboratory Site Tour Around Evaluation Evidence when a renewal depends on evidence gathered on site rather than on a chargeback review.

A dependency map beats a hopeful timeline every time. Once you know who owns the rate, who owns governance, and who owns the signature, the renewal stops being a guessing game and turns into a plan with real dates attached to it.

You can rehearse this exact conversation in the Biotechnology practice conversations library before it happens for real. When you have this one down, read Surface Dependencies for a Shared Platform Renewal Before a Commercial Review next.